Cationic lipid-mediated transfection of cells in culture requires mitotic activity

Gene Therapy

Volumn 6, Issue 3, 1999, Pages 403-411

  Mortimer, I ^a   Tam, P ^a   MacLachlan, I ^a   Graham, R W ^a   Saravolac, E G ^a   Joshi, P B ^a  

^a Inex Pharmaceuticals Corporation   (Canada)

Author keywords

Cationic lipids; Cell cycle; Gene therapy

Indexed keywords

APHIDICOLIN; LIPID;

ARTICLE; CANCER CELL CULTURE; CELL CULTURE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL DIVISION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; MITOSIS; OVARY CARCINOMA; PRIORITY JOURNAL; REPORTER GENE;

CATIONS; CELL CYCLE; FEMALE; GENE EXPRESSION; GENE THERAPY; GENETIC VECTORS; HUMANS; LIPIDS; LUCIFERASES; OVARIAN NEOPLASMS; SEMLIKI FOREST VIRUS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033038501     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3300837     Document Type: Article

References (30)

1. Felgner PL et al. Lipofectin: a highly efficient lipid-mediated DNA transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7417.
2. Felgner PL et al. Improved cationic lipid formulations for in vivo gene therapy. Ann NY Acad Sci 1995; 772: 126-139.
3. Gao X, Huang L. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem Biophys Res Commun 1991; 179: 280-285.
4. Caplen NJ et al. Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med 1995; 1: 39-46.
5. Nabel GJ et al. Immune response in human melanoma after transfection of an allogenic class I major histocompatibility complex gene with DNA liposome. Proc Natl Acad Sci USA 1996; 93: 15388-15399.
6. Gill DR et al. A placebo controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Therapy 1997; 4: 199-209.
7. Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995; 270: 18997-19007.
8. Wrobel I, Collins D. Fusion of cationic liposomes with mammalian cells occurs after endocytosis. Biochim Biophys Acta 1995; 1235: 296-304.
9. Xu Y, Szoka FC Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996; 35: 5616-5623.
10. Friend DS, Papahadjopoulos D, Debs RJ. Endocytosis and intracellular processing accompanying transfection mediated by cationic liposomes. Biochim Biophys Acta 1996; 1278: 41-50.
11. Wilke M et al. Efficacy of a peptide-based gene delivery system depends on mitotic activity. Gene Therapy 1996; 3: 1133-1142.
12. Nicolau C, Sene C. Liposome-mediated DNA transfer in eukaryotic cells. Biochim Biophys Acta 1982; 721: 185-190.
13. Fasbender A, Zabner J, Zeiher BG, Welsh MJ. A low rate of cell proliferation and reduced DNA uptake limit cationic lipid-mediated gene transfer to primary cultures of ciliated human airway epithelia. Gene Therapy 1997; 4: 1173-1180.
14. Jiang C et al. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum Gene Ther 1998; 9: 1531-1542.
15. Bukrinsky MI et al. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature 1993; 365: 666-669.
16. Naldini L et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996; 272: 263-267.
17. von Schwedler U, Kornbluth RS, Trono D. The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc Natl Acad Sci USA 1994; 91: 6992-6996.
18. Felgner PL et al. Nomenclature for synthetic gene delivery systems. Hum Gene Ther 1997; 8: 511-512.
19. Wheeler J et al. Stabilized plasmid-lipid particles: construction and characterization. Gene Therapy 1999 (in press).
20. Ikegami S et al. Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha. Nature 1978; 275: 458-460.
21. Wahl AF et al. Properties of two forms of DNA polymerase delta from calf thymus. Biochemistry 1986; 25: 7821-7827.
22. Tseng W-C et al. Cationic liposomal delivery of plasmid to endothelial cells measured by quantitative flow cytometry. Biotechnol Bioeng 1996; 50: 548-554.
23. Tseng W-C, Haselton FR, Giorgio TD. Transfection of cationic liposomes using simultaneous single cell measurements of plasmid delivery and transgene expression. J Biol Chem 1997; 272: 25641-25647.
24. Mulligan RC. The basic science of gene therapy. Science 1993; 260: 926-932.
25. Verma IM. Gene therapy: hopes, hypes, and hurdles. Molec Med 1994; 1: 2-3.
26. Greber UF et al. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 1993; 75: 477-486.
27. Dowty J et al. Plasmid DNA entry into postmitotic nuclei of primary rat myotubules. Proc Natl Acad Sci USA 1995; 92: 4572-4576.
28. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. Cold Spring Harbor: New York, 1981, pp 93-94.
29. Liljestrom P, Garoff, H. Expression of proteins using Semliki forest virus vectors. In: Ausubel FM et al (eds). Current Protocols in Molecular Biology. John Wiley: Canada, 1994 (Suppl. 28), pp 16.20.1-16.20.16.
30. Lechardeur D et al. Metabolic instability of plasmid DNA in the cytosol; a potential barrier to gene transfer. Gene Therapy 1999 (in press).